In line with this, we found that DNAm AA was positively associated with ESR1 and PGR expression but negatively associated with tumor aggressiveness and genomic instability measures, including TP53 mutation status/RNA-based functional status, tumor mutational burden, HRD score, and percent of genome influenced by SCNAs. The gene discussed is TP53; the disease is neoplasm.